Literature DB >> 26101322

Targeting Antigen to Clec9A Primes Follicular Th Cell Memory Responses Capable of Robust Recall.

Yu Kato1, Ali Zaid1, Gayle M Davey1, Scott N Mueller1, Stephen L Nutt2, Dimitra Zotos2, David M Tarlinton2, Ken Shortman2, Mireille H Lahoud3, William R Heath4, Irina Caminschi5.   

Abstract

Targeting Ags to dendritic cell (DC) surface receptors can induce a variety of responses depending on the DC type targeted, the receptor targeted, and the adjuvant used. Clec9A (DNGR-1), which is expressed by CD8(+) DCs, has been shown to bind F-actin exposed on damaged cells. Targeting Ag to this receptor in mice and nonhuman primates induces strong humoral immunity even in the absence of adjuvant, a process seen for a few select DC receptors. In contrast with other receptors, however, targeting Clec9A induces long-lived, affinity-matured Ab responses that are associated with efficient CD4(+) T cell responses shown to possess properties of follicular Th cells (TFH). In this article, we provide definitive evidence that Clec9A targeting promotes the development of TFH by showing that responding CD4 T cells express CXCR5, PD1, the TFH transcription factor Bcl6, and the cytokine IL-21, and that these cells localize to germinal centers. Furthermore, we extend studies from the model Ag OVA to the viral Ag glycoprotein D of HSV-1 and examine the capacity of primed TFH to form functional memory. We show that targeting glycoprotein D to Clec9A even in the absence of adjuvant induced long-lived memory CXCR5(+) PD1(hi) CD4(+) T cells that proliferated extensively upon secondary challenge and rapidly developed into effector TFH. This was associated with enhanced germinal center B cell responses and accelerated Ab production. Our study indicates that targeting Ags to Clec9A in the absence of adjuvant routinely generates TFH responses that form long-lived memory capable of robust secondary TFH responses.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26101322     DOI: 10.4049/jimmunol.1500767

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  34 in total

1.  Development of a Novel CD4+ TCR Transgenic Line That Reveals a Dominant Role for CD8+ Dendritic Cells and CD40 Signaling in the Generation of Helper and CTL Responses to Blood-Stage Malaria.

Authors:  Daniel Fernandez-Ruiz; Lei Shong Lau; Nazanin Ghazanfari; Claerwen M Jones; Wei Yi Ng; Gayle M Davey; Dorothee Berthold; Lauren Holz; Yu Kato; Matthias H Enders; Ganchimeg Bayarsaikhan; Sanne H Hendriks; Lianne I M Lansink; Jessica A Engel; Megan S F Soon; Kylie R James; Anton Cozijnsen; Vanessa Mollard; Alessandro D Uboldi; Christopher J Tonkin; Tania F de Koning-Ward; Paul R Gilson; Tsuneyasu Kaisho; Ashraful Haque; Brendan S Crabb; Francis R Carbone; Geoffrey I McFadden; William R Heath
Journal:  J Immunol       Date:  2017-10-30       Impact factor: 5.422

Review 2.  Monocyte differentiation and antigen-presenting functions.

Authors:  Claudia V Jakubzick; Gwendalyn J Randolph; Peter M Henson
Journal:  Nat Rev Immunol       Date:  2017-04-24       Impact factor: 53.106

Review 3.  T Follicular Helper Cell Biology: A Decade of Discovery and Diseases.

Authors:  Shane Crotty
Journal:  Immunity       Date:  2019-05-21       Impact factor: 31.745

Review 4.  C-type lectin receptors in the control of T helper cell differentiation.

Authors:  Teunis B H Geijtenbeek; Sonja I Gringhuis
Journal:  Nat Rev Immunol       Date:  2016-06-13       Impact factor: 53.106

Review 5.  Distinct and complementary roles of CD4 T cells in protective immunity to influenza virus.

Authors:  Andrea J Sant; Katherine A Richards; Jennifer Nayak
Journal:  Curr Opin Immunol       Date:  2018-04-02       Impact factor: 7.486

Review 6.  Antigen presentation by dendritic cells and their instruction of CD4+ T helper cell responses.

Authors:  Kerry L Hilligan; Franca Ronchese
Journal:  Cell Mol Immunol       Date:  2020-05-20       Impact factor: 11.530

Review 7.  Dendritic Cell Strategies for Eliciting Mutation-Derived Tumor Antigen Responses in Patients.

Authors:  Sreekumar Balan; John Finnigan; Nina Bhardwaj
Journal:  Cancer J       Date:  2017 Mar/Apr       Impact factor: 3.360

Review 8.  Dendritic cell-based immunotherapy.

Authors:  Rachel L Sabado; Sreekumar Balan; Nina Bhardwaj
Journal:  Cell Res       Date:  2016-12-27       Impact factor: 25.617

9.  Targeting CLEC9A delivers antigen to human CD141+ DC for CD4+ and CD8+T cell recognition.

Authors:  Kirsteen M Tullett; Ingrid M Leal Rojas; Yoshihito Minoda; Peck S Tan; Jian-Guo Zhang; Corey Smith; Rajiv Khanna; Ken Shortman; Irina Caminschi; Mireille H Lahoud; Kristen J Radford
Journal:  JCI Insight       Date:  2016-05-19

10.  Display of Native Antigen on cDC1 That Have Spatial Access to Both T and B Cells Underlies Efficient Humoral Vaccination.

Authors:  Yu Kato; Thiago M Steiner; Hae-Young Park; Rohan O Hitchcock; Ali Zaid; Jyh Liang Hor; Sapna Devi; Gayle M Davey; David Vremec; Kirsteen M Tullett; Peck S Tan; Fatma Ahmet; Scott N Mueller; Sylvie Alonso; David M Tarlinton; Hidde L Ploegh; Tsuneyasu Kaisho; Lynette Beattie; Jonathan H Manton; Daniel Fernandez-Ruiz; Ken Shortman; Mireille H Lahoud; William R Heath; Irina Caminschi
Journal:  J Immunol       Date:  2020-08-24       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.